Sachdev Thomas

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

Suresh S. Ramalingam, Michael L. Maitland, Paul Frankel et al. · Journal of Clinical Oncology · 2009 · 270 citations

Medicine, Oncology, Pharmacology +16

Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2

Rogério Lilenbaum, Rita Axelrod, Sachdev Thomas et al. · Journal of Clinical Oncology · 2008 · 178 citations · Full text

Medicine, Oncology, Pharmacology +14

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (Alliance)

Neal Ready, Herbert Pang, Lin Gu et al. · Journal of Clinical Oncology · 2015 · 136 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial

Nitin Jain, Emily Curran, Neil M. Iyengar et al. · Clinical Cancer Research · 2013 · 111 citations · Full text

Medicine, Oncology, Pharmacology +15

A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503

Anne M. Traynor, Ju-Whei Lee, Gerald K. Bayer et al. · Investigational New Drugs · 2009 · 110 citations · Full text

Medicine, Oncology, Pharmacotherapy +10